Related Experiment Video
Updated: Jun 14, 2025

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
Published on: May 9, 2025
Dahuang Zhechong Pill Improves Pulmonary Fibrosis through miR-29b-2-5p/HK2 Mediated Glycolysis Pathway
Xiao-Yan He1, Jing-Tao Liang2, Jing-Yi Xiao1
1College of Public Health, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China.
Objective:
To explore the preventive and therapeutic effects of Dahuang Zhechong Pill (DZP) on pulmonary fibrosis and the underlying mechanisms.
Methods:
The first key rate-limiting enzyme hexokinase 2 (HK2) of glycolysis was silenced and over-expressed through small interfering RNA and lentivirus using lung fibroblast MRC-5 cell line, respectively. The cell viability, migration, invasion and proliferation were detected by cell counting kit-8, wound healing assay, transwell assay, and flow cytometry. The mRNA and protein expression levels of HK2 were detected by RT-PCR and Western blotting, respectively. The contents of glucose, adenosine triphosphate (ATP) and lactate in MRC-5 cells were determined by enzyme-linked immunosorbnent assay (ELISA). Then, the relationship between miR-29b-2-5p and HK2 was explored by luciferase reporter gene assay. Pulmonary fibrosis cell model was induced by transforming growth factor-β 1 (TGF-β 1) in MRC-5 cells, and the medicated serum of DZP (DMS) was prepared in rats. MRC-5 cells were divided into control, TGF-β 1, TGF-β 1+10% DMS, TGF-β 1+10% DMS+miR-29b-2-5p inhibitor, TGF-β 1+10% DMS+inhibitor negative control, TGF-β 1+10% DMS+miR-29b-2-5p mimic and TGF-β 1+10% DMS+mimic negative control groups. After miR-29b-2-5p mimics and inhibitors were transfected into MRC-5 cells, all groups except control and model group were treated with DMS. The effect of DMS on MRC-5 cells were detected using aforementioned methods and immunofluorescence. Similarly, the contents of glucose, ATP and lactate in each group were measured by ELISA.
Results:
The mRNA and protein expressions of HK2 in MRC-5 cells were successfully silenced and overexpressed through si-HK2-3 and lentiviral transfection, respectively. After silencing HK2, the mRNA and protein expressions of HK2 were significantly decreased (P<0.01), and the concentrations of glucose, ATP and lactate were also significantly decreased (P<0.05). The proliferation, migration and invasion of MRC-5 cells were significantly declined (P<0.05 or P<0.01), while the apoptosis of MRC-5 cells was significantly increased (P<0.01). After overexpressing HK2, the mRNA and protein expressions of HK2 were significantly increased (P<0.05), and the concentrations of glucose, ATP and lactate were also significantly increased (P<0.05 or P<0.01). The proliferation, migration and invasion of MRC-5 cells were significantly increased (P<0.05 or P<0.01), while the apoptosis of MRC-5 cells was significantly decreased (P<0.05). The relative luciferase activity of 3'UTR-WT+hsa-miR-29b-2-5p transfected with HK2 was significantly decreased (P<0.01). After miR-29b-2-5p mimic and inhibitor were transfected into the MRC-5 cells, DMS intervention could significantly reduce the concentration of glucose, ATP and lactate, and the mRNA and proteins expressions of HK2, phosphofructokinase and pyruvate kinase isoform M2 (P<0.05 or P<0.01). The proliferation, migration and invasion of MRC-5 cells were alleviated (P<0.05 or P<0.01), and the deposition of fibronectin, α-smooth muscle actin, and collagen I were significantly decreased (P<0.05 or P<0.01).
Conclusions:
Glycolysis is closely related to pulmonary fibrosis. DZP reduced glycolysis and inhibited fibroblasts' excessive differentiation and abnormal collagen deposition through the miR-29b-2-5p/HK2 pathway, which played a role in delaying the process of pulmonary fibrosis.
Insights
Dahuang Zhechong Pill (DZP) can treat pulmonary fibrosis by reducing glycolysis and inhibiting fibroblast activity. This traditional Chinese medicine utilizes the miR-29b-2-5p/HK2 pathway to slow fibrosis progression.
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- Pulmonary fibrosis is a debilitating lung disease characterized by excessive extracellular matrix deposition.
- Glycolysis plays a critical role in the proliferation and differentiation of lung fibroblasts, key drivers of fibrosis.
- Dahuang Zhechong Pill (DZP) is a traditional Chinese medicine with potential anti-fibrotic properties.
Purpose of the Study:
- To investigate the preventive and therapeutic effects of DZP on pulmonary fibrosis.
- To elucidate the underlying molecular mechanisms, focusing on the miR-29b-2-5p/HK2 pathway and glycolysis.
Main Methods:
- Silencing and overexpression of hexokinase 2 (HK2) in MRC-5 lung fibroblasts.
- Assessing cell viability, migration, invasion, proliferation, and apoptosis.
- Measuring glucose, ATP, and lactate levels.
- Investigating the miR-29b-2-5p and HK2 interaction using luciferase reporter assays.
- Inducing pulmonary fibrosis in vitro and treating with DZP-medicated serum (DMS).
Main Results:
- HK2 manipulation significantly altered fibroblast proliferation, migration, invasion, and apoptosis.
- DZP treatment reduced glycolysis, HK2 expression, and extracellular matrix deposition (fibronectin, α-smooth muscle actin, collagen I) in fibrotic lung cells.
- The miR-29b-2-5p/HK2 pathway was confirmed to be involved in DZP's anti-fibrotic effects.
Conclusions:
- Glycolysis is a critical factor in pulmonary fibrosis development.
- DZP exerts anti-fibrotic effects by modulating glycolysis via the miR-29b-2-5p/HK2 pathway.
- DZP shows therapeutic potential for pulmonary fibrosis by inhibiting fibroblast differentiation and collagen deposition.

